Insight Molecular Diagnostics (IMDX) Goodwill (2020 - 2023)

Insight Molecular Diagnostics has disclosed Goodwill across 4 years of filings, most recently posting $9.5 million for Q3 2023.

• Goodwill for Q3 2023 came in at $9.5 million, down 49.15% year-over-year; the trailing twelve-month figure through Sep 2023 was $9.5 million (down 49.15% YoY), and the FY2022 annual result was $9.2 million, down 50.76% from the prior year.
• Goodwill came in at $9.5 million for Q3 2023 at Insight Molecular Diagnostics, roughly flat from $9.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $24.2 million in Q2 2021 to a low of $9.2 million in Q1 2020.
• The 4-year median for Goodwill is $9.5 million (2023), against an average of $13.4 million.
• Across the five-year window, Goodwill soared 163.82% in 2021 and sank 50.76% in 2022, its largest moves.
• Insight Molecular Diagnostics' Goodwill stood at $9.2 million in 2020, then soared by 103.37% to $18.7 million in 2021, then sank by 50.76% to $9.2 million in 2022, then gained by 3.26% to $9.5 million in 2023.
• The last three Goodwill figures came in at $9.5 million (Q3 2023), $9.5 million (Q2 2023), and $9.5 million (Q1 2023), per Business Quant data.